Publication

Population PK of polymyxin B in critically ill patients receiving continuous venovenous haemofiltration

See how CVVH reduces AUC three‑fold; simulations support 200 mg load + 150 mg q12h…

CertaraMay 5, 2022

Publication

Population Pharmacokinetics of Oral-Based Administration of Cannabidiol in Healthy Adults: Implications for Drug Development

See how uncovered large inter‑individual variability in CBD pharmacokinetics, showing 3.6‑fold exposure differences and long…

CertaraApril 19, 2022

Publication

Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate in Chinese Subjects with and without Hemodialysis-Dependent Stage 5 Chronic Kidney Disease

Discover how evaluated ferric pyrophosphate citrate pharmacokinetics and safety in healthy and hemodialysis‑dependent CKD patients…

CertaraApril 5, 2022

Publication

Population Pharmacokinetic (Pop-PK) Analysis of Torsemide in Healthy Korean Males Considering CYP2C9 and OATP1B1 Genetic Polymorphisms

Explore how CYP2C9 and OATP1B1 genetic effects on torsemide PK in healthy Korean males, supporting…

CertaraApril 1, 2022

Publication

Co-Administration with Voriconazole Doubles the Exposure of Ruxolitinib in Patients with Hematological Malignancies

Find out how voriconazole more than doubles ruxolitinib exposure, supporting dose adjustment guidance for hematologic…

CertaraMarch 25, 2022

Conference

ASCPT 2026 Annual Meeting

CertaraMarch 7, 2022

Publication

Comparative pharmacokinetics and tissue distribution of primaquine enantiomers in mice

See how major PK and metabolic differences between primaquine enantiomers, informing safer and more effective…

CertaraFebruary 5, 2022

Publication

Bioequivalence and Safety Assessment of Two Formulations of Metformin Hydrochloride Sustained-Release Tablets (Yuantang® SR and Glucophage® XR) Under Fed Conditions in Healthy Chinese Adult Subjects: An Open-Label, Two-Way Crossover, Sequence Randomized Phase I Clinical Trial

Learn how the confirmed bioequivalence of metformin SR formulations under fed conditions, with matched PK…

CertaraJanuary 21, 2022

Publication

The effect of nutritional status on the pharmacokinetic profile of acetaminophen+A124:N124

Explore how nutritional status strongly alters acetaminophen PK at toxic doses, with low‑protein diets producing…

CertaraJanuary 20, 2022

White Paper

The Essential Components of Your Drug’s Biomarker Strategy

CertaraJanuary 14, 2022

Clinical Pharmacology

Population PK of polymyxin B in critically ill patients receiving continuous venovenous haemofiltration

Population Pharmacokinetics of Oral-Based Administration of Cannabidiol in Healthy Adults: Implications for Drug Development

Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate in Chinese Subjects with and without Hemodialysis-Dependent Stage 5 Chronic Kidney Disease

Population Pharmacokinetic (Pop-PK) Analysis of Torsemide in Healthy Korean Males Considering CYP2C9 and OATP1B1 Genetic Polymorphisms

Co-Administration with Voriconazole Doubles the Exposure of Ruxolitinib in Patients with Hematological Malignancies

ASCPT 2026 Annual Meeting

Comparative pharmacokinetics and tissue distribution of primaquine enantiomers in mice

Bioequivalence and Safety Assessment of Two Formulations of Metformin Hydrochloride Sustained-Release Tablets (Yuantang® SR and Glucophage® XR) Under Fed Conditions in Healthy Chinese Adult Subjects: An Open-Label, Two-Way Crossover, Sequence Randomized Phase I Clinical Trial

The effect of nutritional status on the pharmacokinetic profile of acetaminophen+A124:N124

The Essential Components of Your Drug’s Biomarker Strategy

Newsletter sign up

Quick links

Solutions

Contact